Intérêt des chambres d’exposition environnementale dans l’évaluation des conjonctivites allergiques

Mortemousque, 2013 Mortemousque, 2008 Abelson, 1990, Conjunctival allergen challenge: a clinical approach to studying allergic conjunctivitis, Arch Ophthalmol, 108, 84, 10.1001/archopht.1990.01070030090035 Research for DE and C., 2019 Day, 1997, Onset of action and efficacy of terfenadine, astemizole, cetirizine, and loratadine for the relief of symptoms of allergic rhinitis, Ann Allergy Asthma Immunol, 79, 163, 10.1016/S1081-1206(10)63104-3 Pfaar, 2017, Allergen exposure chambers: harmonising current concepts and projecting the needs for the future–an EAACI Position Paper, Allergy, 72, 1035, 10.1111/all.13133 Khayath, 2020, Validation of Strasbourg environmental exposure chamber (EEC) ALYATEC® in mite allergic subjects with asthma, J Asthma, 57, 140, 10.1080/02770903.2018.1563902 Gherasim, 2020, Efficacy of air cleaners in asthmatics allergic to cat in ALYATEC® environmental exposure chamber, Clin Exp Allergy, 50, 160, 10.1111/cea.13511 Pfaar, 2014, Recommendations for the standardisation of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper, Allergy, 69, 854, 10.1111/all.12383 Fauquert, 2017, Conjunctival allergen provocation test?: guidelines for daily practice, Allergy, 72, 43, 10.1111/all.12986 European Medicines Agency., 2018 Food and Drug Administration, 2018, Allergic rhinitis: developing drug products for treatment guidance for industry, Allergic Rhinitis, 16 Juniper, 1991, Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis, Clin Exp Allergy, 21, 77, 10.1111/j.1365-2222.1991.tb00807.x Thompson, 2000, Development and validation of the Mini Rhinoconjunctivitis Quality of Life Questionnaire, Clin Exp Allergy, 30, 132, 10.1046/j.1365-2222.2000.00668.x Juniper, 1998, Measuring quality of life in children with rhinoconjunctivitis, J Allergy Clin Immunol, 101, 163, 10.1016/S0091-6749(98)70380-X Juniper, 1994, Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials, J Allergy Clin Immunol, 93, 413, 10.1016/0091-6749(94)90349-2 Bousquet, 2009, Change in visual analog scale score in a pragmatic randomised cluster trial of allergic rhinitis, J Allergy Clin Immunol, 123, 1349, 10.1016/j.jaci.2009.02.033 Demoly, 2013, Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care: asthma and rhinitis, Clin Exp Allergy, 43, 881, 10.1111/cea.12121 European Medicines Agency, 2008 Devillier, 2016, Comparison of outcome measures in allergic rhinitis in children, adolescents and adults, Pediatr Allergy Immunol, 27, 375, 10.1111/pai.12561 Nolte, 2015, Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber, J Allergy Clin Immunol, 135, 1494e6, 10.1016/j.jaci.2014.12.1911 Ellis, 2018, Lack of effect of Timothy grass pollen sublingual immunotherapy tablet on birch pollen-induced allergic rhinoconjunctivitis in an environmental exposure unit, Ann Allergy Asthma Immunol, 120, 495e2, 10.1016/j.anai.2018.02.003 Horak, 2003, Onset and duration of action of ketotifen 0.025 and emedastine 0.05 % in seasonal allergic conjunctivitis: efficacy after repeated pollen challenges in the Vienna Challenge Chamber, Clin Drug Investig, 23, 329, 10.2165/00044011-200323050-00003 Jacobs, 2017, Redness response phenotypes of allergic conjunctivitis in an allergen challenge chamber, Ann Allergy Asthma Immunol, 118, 86e2, 10.1016/j.anai.2016.10.023 Bilkhu, 2014, Effectiveness of non-pharmacologic treatments for acute seasonal allergic conjunctivitis, Ophthalmology, 121, 72, 10.1016/j.ophtha.2013.08.007 Goldstein, 2015, A phase 2 exploratory study of a novel interleukin-1 receptor inhibitor (EBI-005) in the treatment of moderate-to-severe allergic conjunctivitis: eye & contact lens, Sci Clin Pract, 41, 145 Jacobs, 2012, Responses to ragweed pollen in a pollen challenge chamber versus seasonal exposure identify allergic rhinoconjunctivitis endotypes, J Allergy Clin Immunol, 130, 122e8, 10.1016/j.jaci.2012.03.031 Gomes, 2013, Exacerbation of signs and symptoms of allergic conjunctivitis by a controlled adverse environment challenge in subjects with a history of dry eye and ocular allergy, Clin Ophthalmol, 7, 157, 10.2147/OPTH.S38732 Madden, 2013, Effect of humidity variations in a controlled environment chamber on tear evaporation after dry eye therapy: eye & contact lens, Sci Clin Pract, 39, 169 Seidman, 2015, Clinical practice guideline: allergic rhinitis, Otolaryngol Head Neck Surg, 152, S1, 10.1177/0194599814561600 Asher, 2006, Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys, Lancet (Lond Engl), 368, 733, 10.1016/S0140-6736(06)69283-0 Leonardi, 2015, Epidemiology of allergic conjunctivitis, Curr Opin Allergy Clin Immunol, 15, 482, 10.1097/ACI.0000000000000204